Jubilant Pharmova Ltd Share Price History
Jubilant Pharmova Ltd
NSE : 09 Nov, 2026
96623.0 (2.4%)
Prev Close
943.0
Open Price
943.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
17283
Today's High / Low
975.0 / 933.8
52 WK High / Low
1162.0 / 786.0
Market Price of Jubilant Pharmova Ltd
1M
1Y
3Y
5Y
Monitoring Jubilant Pharmova Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | 6006 |
| Sales YoY Gr. | - |
| Adj EPS | 36.89 |
| YoY Gr. | - |
| Net Profit (Cr.) | 575 |
| BVPS | 220.61 |
Key Financial Parameters
| Parameter | 2017 |
|---|---|
| Return on Capital Emp. % | 13.98 |
| Op. Profit Mgn % | 22.81 |
| Net Profit Mgn % | 9.57 |
| Debt to Equity % | 1.33 |
Latest Shareholding
Promoters Holdings Over Time
About Jubilant Pharmova Ltd
- Jubilant Pharmova Limited was initially incorporated as 'Vam Organic Chemicals Limited' on June 21, 1978.
- Company name was changed to 'Jubliant Organosys Limited' in November, 2001 and was again changed to 'Jubilant Life Sciences Limited' in October, 2009 and further it attained a new name 'Jubilant Pharmova Limited' in February, 2021. Jubilant Pharmova Limited is a leading player in the US radiopharmaceutical market, supported by a broad product portfolio, in-house API manufacturing, strong supply chain capabilities, and an onshore manufacturing presence in Montreal.
- It is engaged in six businesses, including Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing of sterile injectables, Contract Research Development and Manufacturing, Generics and Proprietary Novel Drugs businesses.
Popular Search
FAQs for Jubilant Pharmova Ltd Share Price History
What are the key events that typically impact Jubilant Pharmova Ltd's share price history?
Key events that impact Jubilant Pharmova Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Jubilant Pharmova Ltd's share price history?
Stock splits reduce the nominal price of Jubilant Pharmova Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Jubilant Pharmova Ltd?
Dividends can influence Jubilant Pharmova Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Jubilant Pharmova Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Jubilant Pharmova Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Jubilant Pharmova Ltd’s share price history?
To understand Jubilant Pharmova Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
